Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (111-120 of 348) with videos related to

Pageof 35
Sort By:
BJC Reports|November 8, 2024
A Phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Liver Cancer|August 11, 2022
Regression of Tumor Thrombus in the Suprahepatic Vena Cava of Hepatocellular Carcinoma and Conversion Hepatectomy Induced by LenvatinibRyota Matsuki, Naohiro Okano, Takaaki Arai, et al.
Japanese Journal of Clinical Oncology|February 21, 2018
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, et al.
Cancer Science|February 14, 2014
Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinomaMasafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2009
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancerJunji Furuse, Takuji Okusaka, Shinichi Ohkawa, et al.
The Journal of Dermatology|February 24, 2011
Sorafenib-associated hand-foot syndrome in Japanese patientsMasafumi Iijima, Koichi Fukino, Masatoshi Adachi, et al.
Japanese Journal of Clinical Oncology|December 2, 2010
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinomaEiichiro Suzuki, Junji Furuse, Masafumi Ikeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2010
[Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron due to hemolysis after chemotherapy including 5-FU]Yuko Hosokawa, Shigeatsu Motoori, Tomoe Miyazawa, et al.
Japanese Clinical Medicine|December 24, 2016
<i>KRAS</i> Mutation as a Potential Prognostic Biomarker of Biliary Tract CancersMasaaki Yokoyama, Hiroaki Ohnishi, Kouki Ohtsuka, et al.
Clinical Drug Investigation|August 10, 2012
Current status of hepatocellular carcinoma treatment in Japan: case study and discussion-voting systemMasatoshi Kudo, Ryosuke Tateishi, Tatsuya Yamashita, et al.
Pageof 35

Showing results (111-120 of 348) with videos related to

Sort By:
Pageof 35
BJC Reports|November 8, 2024
A Phase 2 study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Liver Cancer|August 11, 2022
Regression of Tumor Thrombus in the Suprahepatic Vena Cava of Hepatocellular Carcinoma and Conversion Hepatectomy Induced by LenvatinibRyota Matsuki, Naohiro Okano, Takaaki Arai, et al.
Japanese Journal of Clinical Oncology|February 21, 2018
A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)Kohei Nakachi, Masaru Konishi, Masafumi Ikeda, et al.
Cancer Science|February 14, 2014
Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinomaMasafumi Ikeda, Shinichi Ohkawa, Takuji Okusaka, et al.
Cancer Chemotherapy and Pharmacology|May 1, 2009
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancerJunji Furuse, Takuji Okusaka, Shinichi Ohkawa, et al.
The Journal of Dermatology|February 24, 2011
Sorafenib-associated hand-foot syndrome in Japanese patientsMasafumi Iijima, Koichi Fukino, Masatoshi Adachi, et al.
Japanese Journal of Clinical Oncology|December 2, 2010
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinomaEiichiro Suzuki, Junji Furuse, Masafumi Ikeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2010
[Two cases of colorectal cancer presenting with periodic, transient elevation of serum iron due to hemolysis after chemotherapy including 5-FU]Yuko Hosokawa, Shigeatsu Motoori, Tomoe Miyazawa, et al.
Japanese Clinical Medicine|December 24, 2016
<i>KRAS</i> Mutation as a Potential Prognostic Biomarker of Biliary Tract CancersMasaaki Yokoyama, Hiroaki Ohnishi, Kouki Ohtsuka, et al.
Clinical Drug Investigation|August 10, 2012
Current status of hepatocellular carcinoma treatment in Japan: case study and discussion-voting systemMasatoshi Kudo, Ryosuke Tateishi, Tatsuya Yamashita, et al.
Pageof 35